Radiation Oncology·Houston, TX

Baylor College of Medicine

Signal lift61%81%+20 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
221–264
p10 – p90
Sample N
157
applicants this cycle
This cycle
no tracked aways yet
Match rate
1.3%
2 of 67 applicants
01Cohort funnelthis cycle
N = 157
Applied
157
100.0%
Invited
67
42.7%
Class size
2
1.3%
J-1 visaAdvanced
Your fitBaylor College of Medicine Program

Create a free profile to see your personalized fit

Get started
Contact
AE
Program Director
Alfredo Enrique Echeverria, MD, MS
Email director
CS
Program Coordinator
Crystal D Sutton, AA
Email coordinator
Training sites5 hospitals · Houston
  • 1
    Harris Health System-Ben Taub Hospital
    Houston, TX
    Primary
  • 2
    Baylor College of Medicine
    Houston, TX
    Sponsor
  • 3
    Michael E DeBakey VA Medical Center (Houston)
    Houston, TX
    Participant
  • 4
    Baylor St Luke's Medical Center
    Houston, TX
    Participant
  • 5
    University of Texas M D Anderson Cancer Center
    Houston, TX
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK221264
180205230255280

Level 2 CE data not available

Interview rates
US MD
53%
US DO
33%
US IMG
22%
Non-US IMG
32%
Applicant origin
In-state
94%
Out-of-state
36%
Interview prepRadiation Oncology
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesRadiation Oncology · 25-26
Save this program

Add Baylor College of Medicine to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Radiation Oncology.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.